Research Briefing
Product Regulation and Metrology Bill [HL]: progress of the bill
The Product Regulation and Metrology Bill [HL] is scheduled to have its report stage in the House of Commons on 4 June 2025.
-
-
Debate Pack
Debate on research and treatment of brain tumours
A debate has been scheduled in the Commons Chamber for 8 May on research and treatment of brain tumours. The subject for this debate has been chosen by the Backbench Business Committee.
-
Debate Pack
Debate on an e-petition relating to the use of dogs in scientific and regulatory procedures
A debate has been scheduled in Westminster Hall for 28 April on an e-petition relating to the use of dogs in scientific and regulatory procedures.
-
Research Briefing
Product Regulation and Metrology Bill [HL] 2024-25
MPs will debate the Product Regulation and Metrology Bill [HL] at second reading on Tuesday 1 April 2025. The bill contains measures concerning the UK’s product safety, regulation and metrology framework.
-
Debate Pack
Debate on the first anniversary of the Hughes report on valproate and pelvic mesh
A Westminster Hall debate has been scheduled for 3pm on 27 March on the first anniversary of the Hughes report on valproate and pelvic mesh. The subject for the debate has been chosen by the Backbench Business Committee, and the debate will be opened by Sharon Hodgson MP.
-
Debate Pack
Debate on prevention of drugs deaths
A debate has been scheduled in Westminster Hall at 1.30pm on 27 March on prevention of drugs deaths. The subject for the debate has been chosen by the Backbench Business Committee, and the debate will be opened by Jim Shannon MP.
-
Research Briefing
Medical use of cannabis
Cannabis is a controlled drug in the UK. Cannabis-based medicines can be prescribed by specialist doctors, but few such medicines have product licences.
-
Debate Pack
Debate on innovation in the field of rare retinal disease
A debate has been scheduled in Westminster Hall for 3pm on 23 January on innovation in the field of rare retinal disease. The subject for the debate has been chosen by the Backbench Business Committee, and the debate will be opened by Jim Shannon MP.
-
Debate Pack
Debate on a motion on the performance of the Medicines and healthcare products regulatory agency
A debate has been scheduled in the Commons Chamber for 16 January on a motion on the performance of the Medicines and healthcare products regulatory agency. The subject for the debate has been chosen by the Backbench Business Committee, and the debate will be opened by Esther McVey MP.
-
Debate Pack
Debate on pelvic mesh and the Cumberlege review
A general debate has been scheduled in the Commons Chamber for 5 December on pelvic mesh and the Cumberlege review. The subject of this debate was chosen by the Backbench Business Committee and the debate will be opened by Chris Vince MP.
-
Research Briefing
Misuse of drugs: regulation and enforcement
Current UK legislation to control drugs, the enforcement of drug laws and calls for reform to the classification of drugs in the UK.
-
Research Briefing
“Netflix” for antimicrobials: The Antimicrobial Products Subscription Model
The NHS will pay a subscription fee to pharmaceutical companies, which will give it access to new antimicrobial drugs for drug-resistant infections.
-
Insight
“Netflix” for antimicrobials: The Antimicrobial Products Subscription Model
The NHS will pay a subscription fee to pharmaceutical companies, which will give it access to new antimicrobial drugs for drug-resistant infections.
-
Research Briefing
Hormone pregnancy tests
Pregnancy tests that involved taking tablets containing hormones were used from the late 1950s until the 1970s in the UK. The use of these medicines has been linked to birth abnormalities but the evidence is disputed.
-
Debate Pack
Debate on premature deaths from heart and circulatory disease
February is World Heart Month. A debate on ‘Premature deaths from heart and circulatory diseases’ has been scheduled for 22 February 2024 in the Commons Chamber. The debate will be led by Dean Russell MP.
Total results (page 3 of 4)